Religare Enterprises Ltd
Religare Enterprise Ltd, incorporated in 1984, is a diversified financial services company with presence all over India, operating through its subsidiaries. The Co. provides loans to SMEs, Affordable Housing Finance, Health Insurance and Retail Broking. REL’s subsidiaries service over 11 lakh clients from over 1,275 locations having presence in more than 400 cities.[1][2]
- Market Cap ₹ 7,791 Cr.
- Current Price ₹ 226
- High / Low ₹ 285 / 197
- Stock P/E
- Book Value ₹ 74.1
- Dividend Yield 0.00 %
- ROCE -1.28 %
- ROE -1.48 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Stock is trading at 3.13 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -48.2% over past five years.
- Promoter holding is low: 30.6%
- Company has a low return on equity of -2.10% over last 3 years.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114 | 497 | 35 | 57 | 33 | 21 | 114 | 28 | 32 | 23 | 39 | 4 | 6 | |
| 11 | 8 | 30 | 346 | 136 | 194 | 49 | 52 | 56 | 66 | 62 | 44 | 50 | |
| Operating Profit | 103 | 490 | 5 | -290 | -102 | -174 | 64 | -25 | -24 | -43 | -23 | -39 | -43 |
| OPM % | 91% | 98% | 13% | -508% | -307% | -845% | 57% | -88% | -76% | -185% | -60% | -931% | -669% |
| 0 | -279 | -7 | 15 | 2 | -130 | 5 | 2 | 24 | 2 | 3 | 12 | 11 | |
| Interest | 194 | 110 | 156 | 57 | 45 | 6 | 4 | 2 | 12 | 25 | 15 | 4 | 3 |
| Depreciation | 3 | 2 | 0 | 2 | 1 | 1 | 1 | 2 | 3 | 6 | 5 | 2 | 2 |
| Profit before tax | -93 | 99 | -158 | -333 | -146 | -310 | 64 | -27 | -15 | -72 | -41 | -34 | -37 |
| Tax % | 11% | 16% | 1% | -2% | 0% | 0% | 1% | -3% | -0% | -9% | -9% | -0% | |
| -104 | 84 | -159 | -326 | -146 | -310 | 64 | -26 | -15 | -65 | -38 | -34 | -37 | |
| EPS in Rs | -5.80 | 4.70 | -8.93 | -18.28 | -6.73 | -12.02 | 2.47 | -0.82 | -0.47 | -1.98 | -1.14 | -1.02 | -1.11 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -38% |
| 5 Years: | -48% |
| 3 Years: | -49% |
| TTM: | 74% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 9% |
| 3 Years: | 0% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -2% |
| 3 Years: | -2% |
| Last Year: | -1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 178 | 178 | 178 | 178 | 217 | 258 | 259 | 319 | 324 | 330 | 331 | 333 |
| Reserves | 2,253 | 2,337 | 1,679 | 1,330 | 1,442 | 1,252 | 1,320 | 1,819 | 1,823 | 1,793 | 1,759 | 2,134 |
| 750 | 844 | 1,302 | 548 | 381 | 333 | 339 | 93 | 219 | 140 | 44 | 6 | |
| 2,578 | 1,248 | 892 | 186 | 172 | 383 | 243 | 255 | 42 | 141 | 109 | 100 | |
| Total Liabilities | 5,759 | 4,607 | 4,051 | 2,243 | 2,212 | 2,227 | 2,161 | 2,486 | 2,407 | 2,405 | 2,242 | 2,573 |
| 2 | 1 | 0 | 2 | 1 | 2 | 4 | 15 | 16 | 20 | 11 | 6 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 5,319 | 4,338 | 3,940 | 2,121 | 2,112 | 2,066 | 1,960 | 2,284 | 2,265 | 2,261 | 2,206 | 2,485 |
| 438 | 268 | 111 | 119 | 98 | 158 | 198 | 187 | 126 | 124 | 26 | 81 | |
| Total Assets | 5,759 | 4,607 | 4,051 | 2,243 | 2,212 | 2,227 | 2,161 | 2,486 | 2,407 | 2,405 | 2,242 | 2,573 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 479 | -93 | 93 | -262 | -26 | -10 | -1 | -19 | -40 | -72 | 73 | -102 | |
| 0 | 0 | -51 | 493 | -86 | -53 | -63 | -311 | 61 | 9 | 59 | -277 | |
| -552 | 94 | -41 | -233 | 115 | 60 | 74 | 320 | 11 | 36 | -131 | 373 | |
| Net Cash Flow | -73 | 1 | 1 | -1 | 3 | -3 | 10 | -10 | 33 | -27 | 2 | -6 |
| Free Cash Flow | 479 | -93 | 93 | -266 | -25 | -11 | -1 | -23 | -40 | -74 | 73 | -102 |
| CFO/OP | 467% | -18% | 2,037% | 91% | 25% | 6% | -2% | 78% | 165% | 167% | -316% | 260% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -2,542 | -220 | -9,728 | -766 | -866 | -5,391 | -607 | -2,632 | 199 | -1,329 | -860 | -7,632 |
| ROCE % | 3% | 4% | 0% | -11% | -5% | -7% | 4% | -1% | -0% | -2% | -1% | -1% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Care Health Insurance Gross Written Premium (GWP) Rs. Crore |
|
||||||||||
| Care Health Insurance Investment Book (AUM) Rs. Crore |
|||||||||||
| Care Health Insurance Market Share (SAHI segment) % |
|||||||||||
| Care Health Insurance Number of Branches count |
|||||||||||
| Religare Broking Active Clients thousands |
|||||||||||
| RHDFCL Assets Under Management (AUM) Rs. Crore |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- Transcript of earnings call held on Thursday, August 13, 2026 at 04.00 P.M. IST
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Advertisement- Special Window for transfer and dematerialisation of physical securities
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Audio recording of FY26 Q1 earnings call held on August 13, 2026 made available online.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Publication of Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- CARE report for quarter ended June 30, 2026 shows Rs 1,500 crore warrant proceeds utilized as planned.
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from nse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Concalls
-
Aug 2026Transcript PPT REC
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT
-
Aug 2023TranscriptAI SummaryPPT
-
May 2016TranscriptAI SummaryPPT
-
Feb 2016TranscriptAI SummaryPPT
-
Nov 2015TranscriptAI SummaryPPT
-
Aug 2015TranscriptAI SummaryPPT
Services
A)Lending (15% of the revenue in FY21) Lending and Investments, Financial Advisory Services, Distribution of Third-Party Financial Products. The Co. provides SME Finance through Religare Finvest Ltd.(RFL) and Affordable Housing Finance through Religare Housing Development Finance Corporation Ltd.(RHDFCL)
B)Health Insurance (74.5% of the revenue) Offers products in the retail segment for Health Insurance, Critical Illness, Personal Accident, Top-up Coverage, International Travel Insurance and Maternity along with Group Health Insurance and Group Personal Accident Insurance for corporates through Care Health Insurance Limited (formerly known as Religare Health Insurance Co. Ltd.)[1]
C)Retail Broking (8.5% of the revenue)Broking in Securities and Commodities, Custodial and Depository Operations, PMS, Institutional Equities and Investment Banking Services through Religare Broking Ltd.[2] [3]